Wednesday, May 30, 2018 12:29:16 AM
https://www.thestreet.com/story/13519277/1/this-drug-company-loaned-its-now-fired-ceo-2-5m-for-made-up-travel-advances.html
Provectus Biopharmaceuticals (PVCT) Chairman and CEO H. Craig Dees was fired after the company's board discovered he allegedly pocketed almost $2.5 million in unsubstantiated travel expenses over the past three years.
The extravagant travel-expense payouts to Dees are real but the actual travel likely isn't, Provectus says, which now leaves the company at risk of criminal or civil investigations by the Securities and Exchange Commission.
The full extent of Dees' alleged embezzlement of company funds -- and the trouble Provectus finds itself in due to his alleged misdeeds -- were disclosed in the company's 10-K filed on March 30.
Provectus is a penny stock that has operated on the dark side of biotech legitimacy for years. The company's long-delayed effort to develop a melanoma treatment made from Rose Bengal, a common stain used to diagnose eye disease, borders on the ridiculous. Most biotech companies try to develop drugs to help patients. A truthful rendering of Provectus' mission statement, on the other hand, would read like, "Striving everyday to transfer as much shareholder cash to executives' pockets as possible."
On this score, Dees was very good at his job.
Soon after Dees was fired in February, Provectus' board hired outside accountants to look into his travel expenses and reimbursements. The investigation found the following:
In 2015, Dees received $898,430 in travel expense "advances." He submitted receipts for that "travel" totaling only $297,170, and most of those receipts "did not appear to be authentic."
In 2014, Dees received $819,000 for travel expense "advances" but didn't submit any travel receipts at all.
In 2013, Dees received $752,034 for travel expenses "advances." He submitted receipts to account for $54,034 of the travel but again, Provectus' investigation found those receipts to be faked.
The amount of money allegedly embezzled by Dees from Provectus over three years is staggering, especially for a company with three full-time employees which has struggled to raise small amounts of money to remain solvent.
Provectus, in its 10-K, does not say where the money given to Dees for "travel" actually ended up. [We can guess the obvious answer.] However, the company does consider all the travel-related expenses of Dees to be "theft loss" and the missing money is being reported to the Internal Revenue Service as extra income to Dees.
That'll be a Form 1099 MISC Dees will have trouble explaining.
Provectus is not the innocent victim of Dees' alleged plundering. Another executive at the company (not identified) approved the travel expense advances given to Dees without any supportive documentation, according to Provectus' 10-K. In essence, Dees asked one of his fellow company executives to write him big checks for travel advances, and that someone just wrote the checks, no questions asked.
In the arcane language of federal securities law, this means Provectus has "material weakness over its internal controls of financial reporting." It's illegal to make a personal loan to an executive or director of a public company.
When the feds call, and they will, Provectus has to explain how $2.5 million in personal loans -- "advances" -- to its now-fired CEO just walked out the door.
Recent PVCT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 12:06:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 12:01:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 11:58:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 10:58:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 10:56:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 09:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 01:54:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 03:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 07:06:10 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 11:23:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 11:19:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 05:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 07:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 09:06:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/23/2024 09:20:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 07:24:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 05:02:31 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/17/2024 08:07:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 07:50:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 01:30:18 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/20/2024 10:03:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:58:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 09:32:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 06:43:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 05:33:53 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM